NCT02314754View on ClinicalTrials.gov

Outpatient Medical Abortion With Mifepristone and Misoprostol Through 77 Days of Gestation

PHASE4CompletedINTERVENTIONAL
Enrollment

719

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Medical Abortion
Interventions
DRUG

Mifepristone followed by misoprostol 24-48 hours later

200mg oral mifepristone and 800mcg buccal misoprostol 24-48 hours after mifepristone

Trial Locations (8)

30342

Atlanta Women's Center, Atlanta

60612

John H. Stroger, Jr. Hospital of Cook CountY, Chicago

60630

Family Planning Associates Medical Group, Chicago

06106

Hartford GYN Center, Hartford

Unknown

Scientific Research Institute of Obstetrics and Gynecology, Baku

David Gagua Clinic, Tbilisi

Clínica Comunitaria Santa Catarina, Mexico City

Hung Vuong Hospital, Ho Chi Minh City

All Listed Sponsors
lead

Gynuity Health Projects

OTHER

NCT02314754 - Outpatient Medical Abortion With Mifepristone and Misoprostol Through 77 Days of Gestation | Biotech Hunter | Biotech Hunter